Alcon Inc (ALC)

$63.78 +1.76 (2.84%)
Market Cap 30.68B
Revenue (ttm) 10.40B
Net Income (ttm) 980.00M
EPS (ttm) N/A
PE Ratio 19.67
Forward PE 18.25
Profit Margin 9.42%
Debt to Equity Ratio 0.21
Volume 2,842,100
Avg Vol 1,738,916
Day's Range N/A - N/A
Shares Out 494.62M
Stochastic %K 14%
Beta 0.93
Analysts Strong Sell
Price Target $88.26

Company Profile

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Veri...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 41 589 112 110
Address:
Chemin de Blandonnet 8, Vernier, Geneva, Switzerland
Estimize
Estimize May. 12 at 8:00 PM
Wall St is expecting 0.77 EPS for $ALC Q2 [Reporting 08/10 AMC] http://www.estimize.com/intro/alc?chart=historical&metric_name=eps&utm_cont
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 12 at 3:19 PM
$ALC zoom zoom zoom
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 12 at 3:19 PM
$ALC loading up
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 12 at 3:18 PM
$ALC this is easy money
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 12 at 1:23 AM
$ALC charging up!!!!
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 11 at 3:59 PM
$ALC getting its footing
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 9 at 2:24 PM
$ALC strong foundation
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 9 at 2:23 PM
$ALC it shook off all the fleas. Bahahahaha
0 · Reply
bravo33
bravo33 May. 8 at 4:21 PM
$ALC This looks sick, can't see adding until it finds and settles on a bottom
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 6 at 1:29 PM
$ALC fly up soon
0 · Reply
Latest News on ALC
Alcon price target lowered to CHF 70 from CHF 77 at Deutsche Bank

2026-05-12T17:26:16.000Z - 18 hours ago

Alcon price target lowered to CHF 70 from CHF 77 at Deutsche Bank

Alcon price target lowered to $78 from $90 at Barclays

2026-05-08T10:12:03.000Z - 5 days ago

Alcon price target lowered to $78 from $90 at Barclays

Alcon price target lowered to $90 from $98 at Baird

2026-05-07T16:04:53.000Z - 5 days ago

Alcon price target lowered to $90 from $98 at Baird

Alcon price target lowered to $85 from $95 at Mizuho

2026-05-07T15:59:58.000Z - 5 days ago

Alcon price target lowered to $85 from $95 at Mizuho

Q1 2026 Alcon AG Earnings Call Transcript

2026-05-07T05:09:54.000Z - 6 days ago

Q1 2026 Alcon AG Earnings Call Transcript

Alcon price target lowered to $70 from $82 at Stifel

2026-05-07T02:23:51.000Z - 6 days ago

Alcon price target lowered to $70 from $82 at Stifel

Alcon (ALC) Q1 2026 Earnings Call Transcript

2026-05-06T16:28:29.000Z - 6 days ago

Alcon (ALC) Q1 2026 Earnings Call Transcript

Alcon Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 7 days ago

Alcon Earnings Call Transcript: Q1 2026

Swiss eye care firm Alcon's quarterly revenue rises, driven by product launches

Wed, 06 May 2026 01:08:16 -0400 - 7 days ago

Swiss eye care firm Alcon's quarterly revenue rises, driven by product launches

Alcon Q1 Profit Falls

2026-05-05T21:39:03.000Z - 7 days ago

Alcon Q1 Profit Falls

New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds

Tue, 05 May 2026 16:30:00 -0400 - 7 days ago

New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds

New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds

2026-05-05T20:30:00.000Z - 7 days ago

New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds

Alcon Announces Results of 2026 Annual General Meeting

Thu, 30 Apr 2026 16:30:00 -0400 - 12 days ago

Alcon Announces Results of 2026 Annual General Meeting

Is Alcon Inc (ALC) a Bargain After 3.4% Drop? GF Value Says Undervalued

2026-04-29T22:22:57.000Z - 13 days ago

Is Alcon Inc (ALC) a Bargain After 3.4% Drop? GF Value Says Undervalued

Alcon Inc (ALC) Stock Down 3.1% -- Now Undervalued? GF Score: 80/100

2026-04-21T22:38:29.000Z - 21 days ago

Alcon Inc (ALC) Stock Down 3.1% -- Now Undervalued? GF Score: 80/100

Alcon price target lowered to $87 from $92 at BTIG

2026-04-13T11:53:30.000Z - 4 weeks ago

Alcon price target lowered to $87 from $92 at BTIG

Mexican Gold Mining Corp.: Mexican Gold Mining Corp. and Alcon Silver Corp. Announce Arrangement Agreement to Create a Diversified Precious Metals Exploration Company

2026-04-09T04:02:00.000Z - 4 weeks ago

Mexican Gold Mining Corp.: Mexican Gold Mining Corp. and Alcon Silver Corp. Announce Arrangement Agreement to Create a Diversified Precious Metals Exploration Company

Alcon Inc (ALC) Trading 3.96% Higher on Apr 8

2026-04-08T17:09:19.000Z - 4 weeks ago

Alcon Inc (ALC) Trading 3.96% Higher on Apr 8

Alcon (ALC) Launches Clareon TruPlus Intraocular Lens in the U.S.

2026-04-06T14:29:55.000Z - 5 weeks ago

Alcon (ALC) Launches Clareon TruPlus Intraocular Lens in the U.S.

Alcon launches Clareon TruPlus at ASCRS 2026

2026-04-06T12:41:33.000Z - 5 weeks ago

Alcon launches Clareon TruPlus at ASCRS 2026

Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026

Mon, 06 Apr 2026 08:03:00 -0400 - 5 weeks ago

Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026

Alcon Publishes Agenda for 2026 Annual General Meeting

Thu, 02 Apr 2026 16:30:00 -0400 - 5 weeks ago

Alcon Publishes Agenda for 2026 Annual General Meeting

Alcon (ALC) Faces $34 Million Verdict in Patent Case

2026-03-30T22:04:39.000Z - 6 weeks ago

Alcon (ALC) Faces $34 Million Verdict in Patent Case

Sight Sciences awarded monetary damages by district court against Alcon

2026-03-30T11:30:29.000Z - 6 weeks ago

Sight Sciences awarded monetary damages by district court against Alcon

SGHT

Lensar upgraded to Buy from Neutral at BTIG

2026-03-17T20:17:07.000Z - 2 months ago

Lensar upgraded to Buy from Neutral at BTIG

LNSR

LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review

2026-03-17T13:04:50.000Z - 2 months ago

LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review

Lensar (LNSR) and Alcon (ALC) Terminate Merger Agreement Amid FTC Concerns

2026-03-16T22:57:40.000Z - 2 months ago

Lensar (LNSR) and Alcon (ALC) Terminate Merger Agreement Amid FTC Concerns

Alcon (ALC) and Lensar Call Off Merger Agreement

2026-03-16T22:31:47.000Z - 2 months ago

Alcon (ALC) and Lensar Call Off Merger Agreement

Alcon (ALC) Ends Merger Talks with Lensar, Impacting Both Stocks

2026-03-16T22:30:53.000Z - 2 months ago

Alcon (ALC) Ends Merger Talks with Lensar, Impacting Both Stocks

Alcon Ends Merger Agreement With LENSAR After FTC Opposition

2026-03-16T22:11:06.000Z - 2 months ago

Alcon Ends Merger Agreement With LENSAR After FTC Opposition

Lensar down 23% following termination of merger agreement with Alcon

2026-03-16T21:05:13.000Z - 2 months ago

Lensar down 23% following termination of merger agreement with Alcon

LNSR

Alcon, Lensar agree to terminate merger agreement

2026-03-16T21:00:45.000Z - 2 months ago

Alcon, Lensar agree to terminate merger agreement

LNSR

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

Mon, 16 Mar 2026 16:57:00 -0400 - 2 months ago

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

LENSAR Announces Termination of Merger Agreement with Alcon Research, LLC

2026-03-16T20:30:00.000Z - 2 months ago

LENSAR Announces Termination of Merger Agreement with Alcon Research, LLC

Glaucoma Research Foundation and Alcon Partner to Expand Access to Trusted Glaucoma Education

Mon, 09 Mar 2026 10:10:00 -0400 - 2 months ago

Glaucoma Research Foundation and Alcon Partner to Expand Access to Trusted Glaucoma Education

Stifel Raises Alcon (ALC) Price Target to $82, Maintains 'Hold' Rating | ALC Stock News

2026-03-09T14:00:45.000Z - 2 months ago

Stifel Raises Alcon (ALC) Price Target to $82, Maintains 'Hold' Rating | ALC Stock News

Alcon price target raised to $82 from $80 at Stifel

2026-03-09T11:17:15.000Z - 2 months ago

Alcon price target raised to $82 from $80 at Stifel

Alcon Earnings Report: Q4 Overview

2026-03-05T12:16:06.000Z - 2 months ago

Alcon Earnings Report: Q4 Overview

Alcon Inc (ALC) Stock Price Down 3.54% on Mar 2

2026-03-02T16:04:55.000Z - 2 months ago

Alcon Inc (ALC) Stock Price Down 3.54% on Mar 2

Alcon Surpasses 175 Million IOLs Implanted Globally

Mon, 02 Mar 2026 08:03:00 -0500 - 2 months ago

Alcon Surpasses 175 Million IOLs Implanted Globally

Alcon Surpasses 175 Million IOLs Implanted Globally

2026-03-02T13:03:00.000Z - 2 months ago

Alcon Surpasses 175 Million IOLs Implanted Globally

Barclays Maintains Rating for Alcon (ALC) and Raises Price Target | ALC Stock News

2026-02-26T15:33:51.000Z - 2 months ago

Barclays Maintains Rating for Alcon (ALC) and Raises Price Target | ALC Stock News

Today's Analyst Upgrade for Alcon (ALC) with New Price Target | ALC Stock News

2026-02-26T15:32:15.000Z - 2 months ago

Today's Analyst Upgrade for Alcon (ALC) with New Price Target | ALC Stock News

Alcon (ALC) Receives Upgrade as Growth Prospects Brighten

2026-02-26T10:25:59.000Z - 2 months ago

Alcon (ALC) Receives Upgrade as Growth Prospects Brighten

Wells Fargo upgrades Alcon to Overweight on new product growth

2026-02-26T10:11:19.000Z - 2 months ago

Wells Fargo upgrades Alcon to Overweight on new product growth

Alcon price target raised to $90 from $86 at Barclays

2026-02-26T10:10:31.000Z - 2 months ago

Alcon price target raised to $90 from $86 at Barclays

Alcon upgraded to Overweight from Equal Weight at Wells Fargo

2026-02-26T10:05:15.000Z - 2 months ago

Alcon upgraded to Overweight from Equal Weight at Wells Fargo

LENSAR Provides Update on Pending Acquisition by Alcon

2026-02-25T22:00:00.000Z - 2 months ago

LENSAR Provides Update on Pending Acquisition by Alcon

Alcon (ALC) Reports Strong Q4 2025 Performance with 7% Sales Growth

2026-02-25T19:02:15.000Z - 2 months ago

Alcon (ALC) Reports Strong Q4 2025 Performance with 7% Sales Growth

Alcon Inc (ALC) (Full Year 2025) Earnings Call Highlights: Strong Revenue Growth Amid Market ...

2026-02-25T19:01:24.000Z - 2 months ago

Alcon Inc (ALC) (Full Year 2025) Earnings Call Highlights: Strong Revenue Growth Amid Market ...

Alcon price target raised to $92 from $91 at BTIG

2026-02-25T16:11:14.000Z - 2 months ago

Alcon price target raised to $92 from $91 at BTIG

Eye-care group Alcon expects product launches to drive 2026 sales, profitability

Feb 25, 2026, 2:26 AM EST - 2 months ago

Eye-care group Alcon expects product launches to drive 2026 sales, profitability

Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales

Feb 24, 2026, 4:30 PM EST - 2 months ago

Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales

Alcon Launches TOTAL30 Multifocal for Astigmatism, the World's Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology

Feb 17, 2026, 8:03 AM EST - 3 months ago

Alcon Launches TOTAL30 Multifocal for Astigmatism, the World's Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology

Alcon Debuts Groundbreaking PRECISION7 in Canada, a One-Week Replacement Contact Lens to Start and End Every Week Fresh

Feb 2, 2026, 9:02 AM EST - 3 months ago

Alcon Debuts Groundbreaking PRECISION7 in Canada, a One-Week Replacement Contact Lens to Start and End Every Week Fresh

Alcon Completes $750 Million Share Repurchase Program

Jan 20, 2026, 4:30 PM EST - 4 months ago

Alcon Completes $750 Million Share Repurchase Program

Alcon Terminates Agreement to Acquire STAAR Surgical

Jan 6, 2026, 8:00 PM EST - 4 months ago

Alcon Terminates Agreement to Acquire STAAR Surgical

STAA

Broadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon

Jan 6, 2026, 9:52 AM EST - 4 months ago

Broadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon

STAA

Staar Surgical to reject Alcon takeover bid after failing to win shareholder backing

Jan 6, 2026, 9:46 AM EST - 4 months ago

Staar Surgical to reject Alcon takeover bid after failing to win shareholder backing

STAA

Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference

Dec 30, 2025, 4:30 PM EST - 4 months ago

Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference

Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon

Dec 19, 2025, 12:59 PM EST - 5 months ago

Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon

STAA

Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders

Dec 19, 2025, 11:45 AM EST - 5 months ago

Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders

STAA

Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.

Dec 17, 2025, 4:53 PM EST - 5 months ago

Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.

STAA

Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails

Dec 17, 2025, 1:17 PM EST - 5 months ago

Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails

STAA

STAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value

Dec 17, 2025, 10:55 AM EST - 5 months ago

STAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value

STAA

Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction

Dec 16, 2025, 9:12 AM EST - 5 months ago

Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction

STAA

Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon

Dec 16, 2025, 7:00 AM EST - 5 months ago

Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon

STAA

Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation “AGAINST” STAAR Surgical Sale to Alcon

Dec 12, 2025, 8:40 AM EST - 5 months ago

Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation “AGAINST” STAAR Surgical Sale to Alcon

STAA

STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process

Dec 11, 2025, 9:47 AM EST - 5 months ago

STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process

STAA

Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon

Dec 11, 2025, 7:00 AM EST - 5 months ago

Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon

STAA

Yunqi Capital Comments on STAAR Surgical's Go-Shop Process and Alcon's Revised Offer

Dec 10, 2025, 7:05 AM EST - 5 months ago

Yunqi Capital Comments on STAAR Surgical's Go-Shop Process and Alcon's Revised Offer

STAA

Broadwood Partners Responds to Alcon's Increase to Proposed Acquisition Price of STAAR Surgical

Dec 9, 2025, 12:39 PM EST - 5 months ago

Broadwood Partners Responds to Alcon's Increase to Proposed Acquisition Price of STAAR Surgical

STAA

Alcon lifts bid for medical technology firm Staar to $1.6 billion

Dec 9, 2025, 9:32 AM EST - 5 months ago

Alcon lifts bid for medical technology firm Staar to $1.6 billion

Alcon Announces Amended Merger Agreement with STAAR Surgical

Dec 9, 2025, 8:30 AM EST - 5 months ago

Alcon Announces Amended Merger Agreement with STAAR Surgical

STAA

Broadwood Partners Reiterates Opposition to STAAR Surgical's Sale to Alcon Following Conclusion of Performative Go-Shop Process

Dec 8, 2025, 1:28 PM EST - 5 months ago

Broadwood Partners Reiterates Opposition to STAAR Surgical's Sale to Alcon Following Conclusion of Performative Go-Shop Process

STAA

Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon

Dec 8, 2025, 8:16 AM EST - 5 months ago

Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon

STAA

STAAR Surgical Announces Expiration of Go-Shop Period

Dec 8, 2025, 8:00 AM EST - 5 months ago

STAAR Surgical Announces Expiration of Go-Shop Period

STAA

Alcon Shares in Switzerland Climb After Guidance Confirmation

Nov 12, 2025, 4:26 AM EST - 6 months ago

Alcon Shares in Switzerland Climb After Guidance Confirmation

Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum Builds

Nov 11, 2025, 4:30 PM EST - 6 months ago

Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum Builds

Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process

Nov 10, 2025, 8:00 AM EST - 6 months ago

Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process

STAA

STAAR Surgical Announces Amendments to Alcon Merger Agreement

Nov 7, 2025, 10:10 AM EST - 6 months ago

STAAR Surgical Announces Amendments to Alcon Merger Agreement

STAA

Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects

Nov 4, 2025, 11:52 AM EST - 6 months ago

Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects

STAA

Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders

Nov 4, 2025, 1:00 AM EST - 6 months ago

Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders

Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon

Oct 31, 2025, 12:00 PM EDT - 6 months ago

Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon

STAA

STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon

Oct 27, 2025, 8:00 AM EDT - 7 months ago

STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon

STAA

Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon

Oct 24, 2025, 6:03 PM EDT - 7 months ago

Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon

STAA

Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction

Oct 24, 2025, 8:00 AM EDT - 7 months ago

Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction

STAA

Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders

Oct 23, 2025, 12:09 PM EDT - 7 months ago

Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders

STAA

Yunqi Capital Issues Letter to STAAR Surgical's Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction

Oct 20, 2025, 5:32 PM EDT - 7 months ago

Yunqi Capital Issues Letter to STAAR Surgical's Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction

STAA

Broadwood Partners Highlights Growing Opposition to STAAR Surgical's Proposed Sale to Alcon

Oct 20, 2025, 8:42 AM EDT - 7 months ago

Broadwood Partners Highlights Growing Opposition to STAAR Surgical's Proposed Sale to Alcon

STAA

Broadwood Partners Issues Letter to STAAR Surgical's Board Urging it to Allow Timely Shareholder Vote on Alcon Sale

Oct 17, 2025, 8:00 AM EDT - 7 months ago

Broadwood Partners Issues Letter to STAAR Surgical's Board Urging it to Allow Timely Shareholder Vote on Alcon Sale

STAA

Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon

Oct 15, 2025, 1:36 PM EDT - 7 months ago

Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon

STAA

Broadwood Partners Comments on STAAR Surgical's Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon

Oct 14, 2025, 2:29 PM EDT - 7 months ago

Broadwood Partners Comments on STAAR Surgical's Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon

STAA

Estimize
Estimize May. 12 at 8:00 PM
Wall St is expecting 0.77 EPS for $ALC Q2 [Reporting 08/10 AMC] http://www.estimize.com/intro/alc?chart=historical&metric_name=eps&utm_cont
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 12 at 3:19 PM
$ALC zoom zoom zoom
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 12 at 3:19 PM
$ALC loading up
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 12 at 3:18 PM
$ALC this is easy money
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 12 at 1:23 AM
$ALC charging up!!!!
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 11 at 3:59 PM
$ALC getting its footing
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 9 at 2:24 PM
$ALC strong foundation
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 9 at 2:23 PM
$ALC it shook off all the fleas. Bahahahaha
0 · Reply
bravo33
bravo33 May. 8 at 4:21 PM
$ALC This looks sick, can't see adding until it finds and settles on a bottom
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 6 at 1:29 PM
$ALC fly up soon
0 · Reply
myman1956
myman1956 May. 6 at 4:49 AM
$ALC This could dip to $70.00 before going higher.
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 6 at 2:46 AM
$ALC this is going to be a rocket tomorrow
1 · Reply
CapitalMonk
CapitalMonk May. 4 at 7:34 PM
$ALC Price: $73.36 (-0.99%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±1.59% RSI: 29.7 | Momentum: Moderate Volume: -3.0% vs avg Volatility: 1.83% Support: $72.42 | Resistance: $82.36 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 3 at 1:59 AM
$ALC great future ahead. Let’s launch together!!!!
0 · Reply
Kingofstocks0001
Kingofstocks0001 May. 3 at 1:59 AM
$ALC this will Explode by 25%
0 · Reply
Blatter
Blatter Apr. 20 at 3:48 PM
$OCGN $ALC then we wait for Alcon from Switzerland to take over!!! 15$!!!
1 · Reply
MansaWells
MansaWells Apr. 17 at 4:09 PM
Today 557 $ALC watchers & next year today 5000+ watchers👀 .. I’ll see you then📅
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 27 at 3:00 AM
$ALC Share Price: $74.49 Contract Selected: Aug 21, 2026 $80 Calls Buy Zone: $3.15 – $3.89 Target Zone: $5.87 – $7.18 Potential Upside: 76% ROI Time to Expiration: 147 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
anachartanalyst
anachartanalyst Mar. 23 at 12:01 PM
$ALC https://anachart.com/wp-content/uploads/ana_temp/1774267271_soc-img.jpg
0 · Reply
TipRanks
TipRanks Mar. 20 at 11:07 AM
Transformational Opportunities: UBS Suggests 2 Longevity Stocks to Buy as the $8T Aging Boom Accelerates https://www.tipranks.com/news/article/transformational-opportunities-ubs-suggests-2-longevity-stocks-to-buy-as-the-8t-aging-boom-accelerates $ABT $ALC
0 · Reply
notreload_ai
notreload_ai Mar. 17 at 11:31 AM
$LNSR and $ALC have mutually terminated their merger after the Federal Trade Commission threatened to block the deal. https://notreload.xyz/lensar-terminates-alcon-merger-after-ftc-block-stock-drops/
0 · Reply